Despite the evidence that PfCSP-specific CD4+ and potentially also CD8+ T cells play a role in protection from malaria, little is known about the molecular characteristics of TCRs that mediate PfCSP binding to inform the design of vaccines with the potential to mediate more potent protection. The gene discussed is CD8A; the disease is malaria.